The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Myopic maculopathy: Current status and proposal for a new classification and grading system (ATN)
Open accessAbstract
Myopia is a highly frequent ocular disorder worldwide and pathologic myopia is the 4th most common cause of irreversible blindness in developed countries. Pathologic myopia is especially common in East Asian countries. Ocular alterations associated with pathologic myopia, especially those involving the macular area-defined as myopic maculopathy-are the leading causes of vision loss in patients with pathologic myopia. High myopia is defined as the presence of a highly negative refractive error (>-6 to -8 diopters) in the context of eye elongation (26-26.5 mm). Although the terms high myopia and pathologic myopia are often used interchangeably, they do not refer to the same eye disease. The two key factors driving the development of pathologic myopia are: 1) elongation of the axial length and 2) posterior staphyloma. The presence of posterior staphyloma, which is the most common finding in patients with pathologic myopia, is the key differentiating factor between high and pathologic myopia. The occurrence of staphyloma will, in most cases, eventually lead to other conditions such as atrophic, traction, or neovascular maculopathy. Posterior staphyloma is for instance, responsible for the differences between a myopic macular hole (MH)-with and without retinal detachment-and idiopathic MH. Posterior staphyloma typically induces retinal layer splitting, leading to foveoschisis in myopic MH, an important differentiating factor between myopic and emmetropic MH. Myopic maculopathy is a highly complex disease and current classification systems do not fully account for the numerous changes that occur in the macula of these patients. Therefore, a more comprehensive classification system is needed, for several important reasons. First, to more precisely define the disease stage to improve follow-up by enabling clinicians to more accurately monitor changes over time, which is essential given the progressive nature of this condition. Second, unification of the currently-available classification systems would establish standardized classification criteria that could be used to compare the findings from international multicentric studies. Finally, a more comprehensive classification system could help to improve our understanding of the genetic origins of this disease, which is clearly relevant given the interchangeable-but erroneous-use of the terms high and pathologic myopia in genetic research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ranibizumab for Neovascular Age-Related Macular Degeneration
Rosenfeld, P. J., Brown, D. M., Heier, J. S., Boyer, D. S., Kaiser, P. K., Chung, C. Y., & Kim, R. Y. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054481 · Cited by 5,886
Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050
Holden, B. A., Fricke, T. R., Wilson, D. A., Jong, M., Naidoo, K. S., Sankaridurg, P., Wong, T. Y., Naduvilath, T. J., & Resnikoff, S. (2016) · Ophthalmology · doi:10.1016/j.ophtha.2016.01.006 · Cited by 5,500
Ranibizumab versus Verteporfin for Neovascular Age-Related Macular Degeneration
Brown, D. M., Kaiser, P. K., Michels, M., Soubrane, G., Heier, J. S., Kim, R. Y., Sy, J. P., & Schneider, S. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062655 · Cited by 3,522
Morgan, I. G., Ohno-Matsui, K., & Saw, S.-M. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60272-4 · Cited by 1,871
Kashani, A. H., Chen, C.-L., Gahm, J. K., Zheng, F., Richter, G. M., Rosenfeld, P. J., Shi, Y., & Wang, R. K. (2017) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2017.07.002 · Cited by 1,006
Klaver, C. C. W. (1998) · Archives of Ophthalmology · doi:10.1001/archopht.116.5.653 · Cited by 881
International Photographic Classification and Grading System for Myopic Maculopathy
Ohno-Matsui, K., Kawasaki, R., Jonas, J. B., Cheung, C. M. G., Saw, S.-M., Verhoeven, V. J. M., Klaver, C. C. W., Moriyama, M., Shinohara, K., Kawasaki, Y., et al. (2015) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2015.01.022 · Cited by 866
Enhanced Depth Imaging Optical Coherence Tomography of the Choroid in Highly Myopic Eyes
Fujiwara, T., Imamura, Y., Margolis, R., Slakter, J. S., & Spaide, R. F. (2009) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2009.04.029 · Cited by 823
Wong, T. Y., Ferreira, A., Hughes, R., Carter, G., & Mitchell, P. (2014) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2013.08.010 · Cited by 758
Role of the sclera in the development and pathological complications of myopia
McBrien, N. (2003) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(02)00063-0 · Cited by 616
Cited by
Brennan, N. A., Toubouti, Y. M., Cheng, X., & Bullimore, M. A. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2020.100923 · Cited by 355
Laíns, I., Wang, J. C., Cui, Y., Katz, R., Vingopoulos, F., Staurenghi, G., Vavvas, D. G., Miller, J. W., & Miller, J. B. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2021.100951 · Cited by 324
Metadata
- Authors
- Ruiz-Medrano, J., Montero, J. A., Flores-Moreno, I., Arias, L., García-Layana, A., & Ruiz-Moreno, J. M.
- Venue
- Progress in Retinal and Eye Research
- Publisher
- Elsevier BV
- Published
- 2019-03
- Volume
- 69
- Pages
- 80-115
- ISSN
- 1350-9462 (ISSN-L)
- OpenAlex
- W2899439961
- Cited by
- 446
- References
- 98
- FWCI
- 23.36
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Myopic maculopathy: Current status and proposal for a new classification and grading system (ATN). https://app.cochat.ai/papers/10.1016/j.preteyeres.2018.10.005
- The paper
- Ruiz-Medrano, J., Montero, J. A., Flores-Moreno, I., Arias, L., García-Layana, A., & Ruiz-Moreno, J. M. (2019). Myopic maculopathy: Current status and proposal for a new classification and grading system (ATN). Progress in Retinal and Eye Research. https://doi.org/10.1016/j.preteyeres.2018.10.005
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.